Oncology and hormone therapy research by Olema Pharmaceuticals
Olema Pharmaceuticals adds new team members amid expansion plans
Olema Pharmaceuticals is actively recruiting new talent as it pursues growth and builds its capabilities for future initiatives. The company emphasized the importance of curiosity, collaboration, ...
Olema Pharmaceuticals ends ASCO26 energized by cancer research momentum
Olema Pharmaceuticals concluded its participation at ASCO26 in Chicago, signaling renewed energy from advancements in cancer science and innovation. The annual meeting, a renowned event for ...
ASCO Annual Meeting features Olema Pharmaceuticals OPERA-02 trial poster presentation in Chicago
Olema Pharmaceuticals is presenting an update on its OPERA-02 trial-in-progress at the ASCO Annual Meeting in Chicago. The company will display its latest research findings in Hall A at ...
Olema Pharmaceuticals presents new OP-3136 and OPERA-02 poster data at ASCO26 in Chicago
Olema Pharmaceuticals introduced findings from its OP-3136 and OPERA-02 programs at the ASCO26 conference in Chicago. The company shared details through poster presentations, aiming to highlight ...
Olema Pharmaceuticals seeks new hires committed to advancing oncology innovation
Olema Pharmaceuticals is inviting prospective candidates to apply for a range of open positions as the company seeks to attract professionals whose ideas and contributions can drive change in the ...
Olema Pharmaceuticals announces first clinical data for OP-3136 KAT6 inhibitor in Phase 1 study
Olema Pharmaceuticals has released the initial clinical data from its Phase 1 study evaluating OP-3136, a KAT6 inhibitor candidate. The announcement marks a key milestone for the company as it ...
Legal operations leadership role opens as Olema Pharmaceuticals launches search for senior manager
Olema Pharmaceuticals is recruiting a Senior Manager of Legal Operations and Contracts to enhance the company legal operations and oversee a broad range of commercial and corporate contracts. The ...
Olema Pharmaceuticals seeks senior director to drive breast cancer marketing strategy
Olema Pharmaceuticals is recruiting an experienced leader in breast cancer to fill the role of Senior Director of Marketing. The company aims to strengthen its go-to-market strategy and ensure ...
Prakash Raman named to Olema Pharmaceuticals board
Olema Pharmaceuticals has announced the addition of Prakash Raman, Ph.D., to its board of directors. The company shared the news in a recent press release, signaling a strategic shift in its ...
Olema Pharmaceuticals seeks lead senior medical writer to strengthen oncology portfolio
Olema Pharmaceuticals has announced an opening for a lead senior medical writer to support the creation of scientific and regulatory documents across its oncology portfolio. This strategic hiring ...
Olema Pharmaceuticals expands workforce to drive oncology innovation
Olema Pharmaceuticals has announced the addition of new hires to its team as part of ongoing efforts to advance cancer medicine development. The company stated that each new team member brings ...
Olema Pharmaceuticals unveils new preclinical data ahead of AACR2026 presentation
Olema Pharmaceuticals has released new preclinical data that will be presented at AACR2026 on Monday, April 20. The company directed stakeholders to access the full data details through an online ...
Olema Pharmaceuticals posts new leadership role to advance clinical study compliance
Olema Pharmaceuticals is recruiting for an associate director of GCP quality assurance to oversee compliance across its clinical studies. The move signals the company’s focus on maintaining ...
Olema Pharmaceuticals seeks senior director to lead accounting operations and financial reporting
Olema Pharmaceuticals has announced a search for a Senior Director of Accounting and Assistant Controller to oversee critical areas of its accounting operations and support the accuracy of its ...
AACR Annual Meeting to feature pre-clinical research from Olema Pharmaceuticals
Olema Pharmaceuticals announced it will present two pre-clinical posters at the 2026 AACR Annual Meeting in San Diego. The event, scheduled for April 17-22, will showcase the company’s latest ...
Olema Pharmaceuticals delivers Q4 and full-year 2025 financial results and updates on milestones
Olema Pharmaceuticals has published its financial and operating results for the fourth quarter and full-year 2025. The company also shared updates on its recent progress and outlined anticipated ...
Olema Pharmaceuticals CEO to join TDCowen Health Care Conference fireside chat in Boston
Olema Pharmaceuticals announced that its President and CEO, Sean Bohen, will participate in a fireside chat at the 46th Annual TDCowen Health Care Conference in Boston. The event is scheduled ...
Olema Pharmaceuticals seeks NDA lead for biotech program
Olema Pharmaceuticals is actively seeking a Senior Director of Program Management to serve as the NDA Lead. This role is pivotal in steering the cross-functional development and regulatory ...
Olema Pharmaceuticals joins SABCS25 to advance breast cancer therapies
Olema Pharmaceuticals participates in the San Antonio Breast Cancer Symposium 2025 (SABCS25) to showcase its advancements in breast cancer therapies. The company has invited attendees to visit ...
Olema Pharmaceuticals seeks senior medical director to advance oncology care
Olema Pharmaceuticals is currently hiring for a Senior Medical Director position focusing on oncology care. The role involves guiding clinical strategy and advancing innovative science in the ...
Olema Pharmaceuticals engages investors at key conferences
Olema Pharmaceuticals is joining several key investor conferences this month across the U.S. and Europe. This strategic move is intended to offer insights into the company's recent advancements ...
